Display options
Cite
Thorkelson SJ, Anderson KR. Oral Medications for Diabetes in Pregnancy: Use in a Rural Population. Diabetes Spectr. 2016;29(2):98-101doi: 10.2337/diaspect.29.2.98.
Thorkelson, S. J., & Anderson, K. R. (2016). Oral Medications for Diabetes in Pregnancy: Use in a Rural Population. Diabetes spectrum : a publication of the American Diabetes Association, 29(2), 98-101. https://doi.org/10.2337/diaspect.29.2.98
Thorkelson, Shelley Jayne, and Anderson, Kristi R. "Oral Medications for Diabetes in Pregnancy: Use in a Rural Population." Diabetes spectrum : a publication of the American Diabetes Association vol. 29,2 (2016): 98-101. doi: https://doi.org/10.2337/diaspect.29.2.98
Thorkelson SJ, Anderson KR. Oral Medications for Diabetes in Pregnancy: Use in a Rural Population. Diabetes Spectr. 2016 May;29(2):98-101. doi: 10.2337/diaspect.29.2.98. PMID: 27182179; PMCID: PMC4865390.
Copy Download .nbib Format: NLM
Share it on

Diabetes Spectr. 2016 May;29(2):98-101. doi: 10.2337/diaspect.29.2.98.

Oral Medications for Diabetes in Pregnancy: Use in a Rural Population.

Diabetes spectrum : a publication of the American Diabetes Association

Shelley Jayne Thorkelson, Kristi R Anderson

Affiliations

  1. Northern Navajo Medical Center, Shiprock, NM.

PMID: 27182179 PMCID: PMC4865390 DOI: 10.2337/diaspect.29.2.98

Abstract

IN BRIEF The oral agents glyburide and metformin are both recommended by many professional societies for the treatment of gestational diabetes mellitus (GDM). Both therapeutic modalities have published safety and efficacy data, but there remains much debate among experts. Providers need a clear treatment plan for GDM based on a predictable level of clinical success in obtaining treatment goals. The proper selection of ideal candidates is paramount in achieving clinical success with the use of these medications in the treatment of GDM. This article presents clinical strategies for using oral agents in the management of GDM based on a pragmatic approach taken in a group of rural Native American women.

References

  1. Obstet Gynecol. 2015 Aug;126(2):303-9 - PubMed
  2. Semin Perinatol. 2014 Dec;38(8):508-15 - PubMed
  3. Drug Saf. 2015 Jan;38(1):65-78 - PubMed
  4. J Matern Fetal Neonatal Med. 2016;29(7):1025-9 - PubMed
  5. N Am J Med Sci. 2015 Jan;7(1):6-12 - PubMed
  6. Curr Diab Rep. 2015 Feb;15(2):570 - PubMed
  7. Obstet Gynecol. 2009 Jan;113(1):193-205 - PubMed
  8. JAMA Pediatr. 2015 May;169(5):427-8 - PubMed
  9. BMJ. 2015 Jan 21;350:h102 - PubMed
  10. Saudi Med J. 2015 Apr;36(4):399-406 - PubMed
  11. Am Fam Physician. 2015 Apr 1;91(7):460-7 - PubMed
  12. Drugs Context. 2015 Jul 15;4:212282 - PubMed
  13. JAMA Pediatr. 2015 May;169(5):452-8 - PubMed
  14. Obstet Gynecol. 2013 Aug;122(2 Pt 1):406-16 - PubMed
  15. Prev Chronic Dis. 2014 Jun 19;11:E104 - PubMed
  16. Obstet Gynecol. 2014 Jun;123(6):1177-84 - PubMed

Publication Types